= Discovery stage.
= Translation stage.
= Clinically available.
MSACL 2018 EU : Marshall

MSACL 2018 EU Abstract

Self-Classified Topic Area(s): Endocrinology

Quantification of Testosterone, Androstenedione and 17-Hydroxyprogesterone Collected Using Mitra Micro Sampling Devices

David Marshall, Brian Keevil
Manchester University NHS Foundation Trust


Warning: Undefined variable $headshot in /var/www/html/view_abstract/view_abstract_in_program.php on line 704
 David Marshall (Presenter)
Manchester University NHS Foundation Trust

Presenter Bio: I am a trainee Clinical Scientist at Wythenshawe Hospital in Manchester. I have worked with clinical mass spectrometry for the last 3 years, including routine operation, method development and troubleshooting. I am also in the process of completing a Masters in Clinical Science as part of my training

Relevant Financial Disclosures (within past 24 months, reported on Jun 27, 2025)
Grant/Research Support Mr
Salary Waters

Abstract

Mitra devices are small polymer tips that absorb a fixed amount of blood which can be dried prior to analysis.

A simple liquid:liquid extraction was used following reconstitution of the mitra device in distilled water. Separation was carried out using a Waters Acquity HSS T3 column which resolved the peaks well.

We have developed an assay for the simultaneous quantification of testosterone, androstenedione and 17-hydroxyprogesterone using a single mitra tip.